Hugel secures the domestic sales rights for ECM-based injectable CellREDM, planning collaboration with Hans Biomed The company aims to create synergies with its botulinum toxin and dermal filler products as a new growth engine SEOUL, South Korea, March 31, 2026 /PRNewswire/ -- Hugel Inc.,...
Hence then, the article about hugel to enter ecm based injectable market with aesthetic portfolio expansion was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hugel to enter ECM-based injectable market with aesthetic portfolio expansion )
Also on site :
- Brendan Penny is ‘So Angry’ After Pal Robert Buckley’s Movie Premiere, But For the Funniest Reason (Exclusive)
- Beloved ’70s Singer-Songwriter, Who Influenced Kate Bush and Radiohead, Became an Icon Decades After His Tragic Death at 26
- Le moteur BC Engine de BC.GAME a dépassé les 10 millions de dollars de récompenses en six mois après son lancement.